Unknown

Dataset Information

0

Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19.


ABSTRACT: Blood myeloid cells are known to be dysregulated in coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2. It is unknown whether the innate myeloid response differs with disease severity and whether markers of innate immunity discriminate high-risk patients. Thus, we performed high-dimensional flow cytometry and single-cell RNA sequencing of COVID-19 patient peripheral blood cells and detected disappearance of non-classical CD14LowCD16High monocytes, accumulation of HLA-DRLow classical monocytes (Human Leukocyte Antigen - DR isotype), and release of massive amounts of calprotectin (S100A8/S100A9) in severe cases. Immature CD10LowCD101-CXCR4+/- neutrophils with an immunosuppressive profile accumulated in the blood and lungs, suggesting emergency myelopoiesis. Finally, we show that calprotectin plasma level and a routine flow cytometry assay detecting decreased frequencies of non-classical monocytes could discriminate patients who develop a severe form of COVID-19, suggesting a predictive value that deserves prospective evaluation.

SUBMITTER: Silvin A 

PROVIDER: S-EPMC7405878 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-BSST416 | biostudies-other
2022-09-22 | E-MTAB-12236 | biostudies-arrayexpress
2023-05-11 | GSE227080 | GEO
2020-10-29 | E-MTAB-9357 | biostudies-arrayexpress
| S-EPMC7902293 | biostudies-literature
2020-08-07 | GSE155673 | GEO
2020-07-31 | GSE152418 | GEO
2021-04-26 | GSE164381 | GEO
2021-04-26 | GSE164380 | GEO
2021-04-26 | GSE164379 | GEO